Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-003288
Filing Date
2019-01-10
Accepted
2019-01-10 17:16:13
Documents
2
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 13289
2 POA DOCUMENT poa.txt EX-24.3_826269 3540
  Complete submission text file 0001209191-19-003288.txt   18161
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38079 | Film No.: 19520913

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations